Difference between revisions of "Stop-doxepin"

From Psychiatrienet
Jump to: navigation, search
(Created page with '{{Drugswitch | from = doxepin | stop = {{StopAlgemeen}} * 150 mg/day: :*'''Day 1:''' reduce dosage of doxepin to 100 mg/day. :*'''Day 8:''' reduce dosage of doxepin to 75 mg/day...')
 
m (moved Stop-doxepine to Stop-doxepin: International name)
(No difference)

Revision as of 15:18, 10 May 2010

Doxepin
Type antidepressant
Group TCA
links
ATC-code N06AA12
Medscape Doxepin
PubChem 3158
PubMed Doxepin
Drugs.com doxepin
Kompas (Dutch) Doxepin
Wikipedia Doxepin


Nietinrijdenbord.png Stop doxepin
  • In general after long-term maintenance treatment, the best is to reduce the dose by about 25% every 4-6 weeks. An apt pharmaceutical dose (tablet, capsule, mixture) is not always available. In these cases one should be creative with dosing.[3][4]
  • Another, more risky, possibility is being at a certain dose to use the following scheme:
  • 150 mg/day:
  • Day 1: reduce dosage of doxepin to 100 mg/day.
  • Day 8: reduce dosage of doxepin to 75 mg/day.
  • Day 15: reduce dosage of doxepin to 50 mg/day.
  • Day 22: reduce dosage of doxepin to 25 mg/day.
  • Day 30: stop the administration of doxepin.



  1. 1.0 1.1 1.2 1.3 1.4 KNMP; Informatorium Medicamentorum 2015; Monografie "doxepine" (Dutch)
  2. NVZA; Toxicology.org; Monografie 63 (dutch)
  3. The UK Drug and Therapeutics Bulletin; 1999;37:49-52
  4. Editor: please note that not all dosages are available in pharmacy. So now and then you should be creative.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.